English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/202743
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity

AuthorsFernández-Díaz, C. CSIC ORCID; Merino, Beatriz; López-Acosta, José Francisco CSIC; Cidad, Pilar CSIC ORCID; Fuente, Miguel A. de la; Lobatón, Carmen D.; Moreno, Alfredo; Leissring, Malcolm A.; Perdomo, Germán; Cózar-Castellano, Irene CSIC ORCID CVN
KeywordsBeta-cell immaturity
GK
Glut1
Glut2
Insulin-degrading enzyme
Insulin secretion
Issue Date2019
PublisherAmerican Physiological Society
CitationAmerican Journal of Physiology - Endocrinology and Metabolism 317(5): E805-E819 (2019)
AbstractInhibition of insulin-degrading enzyme (IDE) has been proposed as a possible therapeutic target for type 2 diabetes treatment. However, many aspects of IDE's role in glucose homeostasis need to be clarified. In light of this, new preclinical models are required to elucidate the specific role of this protease in the main tissues related to insulin handling. To address this, here we generated a novel line of mice with selective deletion of the Ide gene within pancreatic beta-cells, B-IDE-KO mice, which have been characterized in terms of multiple metabolic end points, including blood glucose, plasma C-peptide, and intraperitoneal glucose tolerance tests. In addition, glucose-stimulated insulin secretion was quantified in isolated pancreatic islets and beta-cell differentiation markers and insulin secretion machinery were characterized by RT-PCR. Additionally, IDE was genetically and pharmacologically inhibited in INS-1E cells and rodent and human islets, and insulin secretion was assessed. Our results show that, in vivo, life-long deletion of IDE from beta-cells results in increased plasma C-peptide levels. Corroborating these findings, isolated islets from B-IDE-KO mice showed constitutive insulin secretion, a hallmark of beta-cell functional immaturity. Unexpectedly, we found 60% increase in Glut1 (a high-affinity/low-Km glucose transporter), suggesting increased glucose transport into the beta-cell at low glucose levels, which may be related to constitutive insulin secretion. In parallel, IDE inhibition in INS-1E and islet cells resulted in impaired insulin secretion after glucose challenge. We conclude that IDE is required for glucose-stimulated insulin secretion. When IDE is inhibited, insulin secretion machinery is perturbed, causing either inhibition of insulin release at high glucose concentrations or constitutive secretion.
Publisher version (URL)http://dx.doi.org/10.1152/ajpendo.00040.2019
URIhttp://hdl.handle.net/10261/202743
DOIhttp://dx.doi.org/10.1152/ajpendo.00040.2019
ISSN0193-1849
E-ISSN1522-1555
Appears in Collections:(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.